Table 1.
The top ten drug classes associated with subacute cutaneous lupus erythematosus reported in the US FDA Adverse Event Reporting System database between 1 July 2013 and 30 June 2015, stratified by drug class
| S. no. | Drug class | Reported SCLE cases (n) |
|---|---|---|
| 1 | PPI | 120 |
| 2 | Statins | 34 |
| 3 | Corticosteroids | 27 |
| 4 | Thiazide diuretics | 25 |
| 5 | ACEI/ARB | 22 |
| 6 | Thyroid medications | 20 |
| 7 | Aspirin | 16 |
| 8 | Beta blocker | 15 |
| 9 | Benzodiazepine | 15 |
| 10 | Stool softener | 13 |
ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, PPI proton pump inhibitor, SCLE subacute cutaneous lupus erythematosus